Chapter | Jotup

Attune and ASHRAE IL Chapter volunteers to Install Indoor Air Quality Monitoring Systems in two Illinois Public Schools

Retrieved on:

火曜日, 3月 19, 2024

VIENNA, Va., March 19, 2024 /PRNewswire/ -- Attune, the only customizable indoor air quality monitoring solution in America, along with the Illinois Chapter of ASHRAE, deployed Attune IAQ monitoring systems in Forest Hills Elementary School and McClure Junior High in Western Springs, Illinois.

Key Points:

VIENNA, Va., March 19, 2024 /PRNewswire/ -- Attune, the only customizable indoor air quality monitoring solution in America, along with the Illinois Chapter of ASHRAE, deployed Attune IAQ monitoring systems in Forest Hills Elementary School and McClure Junior High in Western Springs, Illinois.
This is a part of the 2024 ASHRAE Winter Conference Sustainability Project hosted by the Chapter.
"This sustainability project will help showcase indoor air quality in schools and will open up a dialogue on methods to improve it," said Theron.
Attune is currently in over 1,500 schools across the nation, including Denver Public Schools, Washington, D.C. Public Schools, Montgomery County Public Schools, Monterey County Schools, South Monterey County Schools, and Prince William County Public Schools.

American Parkinson Disease Association to Celebrate the Power of a Supportive Community During Parkinson's Disease Awareness Month

Retrieved on:

火曜日, 3月 12, 2024

Diagnosis, Parkinson's disease, Exercise, Chapter, Disease, PD, Education, Information, Research, American Parkinson Disease Association, Optimism, Calendar, Movement, APDA, Palladium

NEW YORK, March 12, 2024 /PRNewswire-PRWeb/ -- April is Parkinson's Disease Awareness Month and the American Parkinson Disease Association (APDA) will commemorate the month by raising awareness of Parkinson's disease (PD) and the importance of connection and community through the theme of Living Better Together. Through a nationwide network of Chapters and Information & Referral (I&R) Centers, APDA works tirelessly to provide the support, education and research that helps people impacted by PD live life to the fullest.

Key Points:

With a PD diagnosis every 6 minutes, awareness is needed now more than ever.
NEW YORK, March 12, 2024 /PRNewswire-PRWeb/ -- April is Parkinson's Disease Awareness Month and the American Parkinson Disease Association (APDA) will commemorate the month by raising awareness of Parkinson's disease (PD) and the importance of connection and community through the theme of Living Better Together.
"Every six minutes there is a new diagnosis of PD, which means that in April alone nearly 7,200 people in this country will learn they have PD.
Now more than ever, it is critical to engage, inform, and support the PD community and raise awareness about this disease, and Parkinson's Disease Awareness Month is a prime time to shine a spotlight on this issue.

US monetary policy is more powerful in low economic growth regimes

Retrieved on:

火曜日, 4月 2, 2024

Tao, Research Papers in Economics, Excess, American Economic Journal, Doan, Policy, RT, Interpolation, Economic growth, Absorption, Business, E32, Low, Browning, European Economic Review, UST, NBER, Forecasting, Macroeconomics, European Economic Association, Journal of Monetary Economics, Journal of Applied Econometrics, TVAR, Oxford University Press, Time series, Economic Inquiry, Paper, Linearity, Joshua Angrist, Nobuhiro, Environment, Political economy, Journal of Financial Economics, Rated R, R2, Website, Emi, Energy economics, Probability, Medical classification, Eurozone, Sigismund, Quarterly Journal of Economics, Zero lower bound, History, Nature, Chapter, ZT, Journal of Political Economy, Bocconi University, OLS, Statistics, University of California, Irvine, PDF, Classification, ECB, XS, ITP, Impact, Estimation, DGP, Mark Thoma, Social science, Elsevier, JEL, Cambridge University Press, Real, M1, Research, Textbook, Private sector, FED, Credit, UTT, Literature, Federal Reserve, Knotek, Evelyn Regner, Table, European Central Bank, Chow, FRED, Monetary economics, Wald, Ben Bernanke, Premium, P500, BIS, EWMA, International Economic Review, Federal funds rate, Money, Treasury, C32, The Economic Journal, Federal Reserve Economic Data, Employment, Risk, FFR, Suggestion, FOMC, Monte Carlo method, Sigmoid, VAR, Database, Projection, Ascari, The Journal of Finance, Yield curve, United States Treasury security, Economy, Fed, Figure, NFCI, Financial economics, EXP, Freedom, Central bank, PCE, Monetary policy, American Economic Review, Exercise, Interest, Samuel, URR, Rigidity, Business cycle, XT, Landing slot, Chap, Daron Acemoglu, Markov, Blue chip, Kuttner, Response, Quarterly Journal, YT, Channel, GDP, Standard, Effect, Federal, Cost, Christian Social Union (UK), Journal of Econometrics, Comm, Mark Gertler, Use, Economic statistics, IW, Bank for International Settlements, Finance Secretary (India), UC, Bank, Reproduction, Section, News, Housing, Data, Food industry

Key Points:

EQS-News: Strong earnings power allows for active risk management in 2023 – consolidated operating profit expected to rise to between €300 million and €350 million in 2024

Retrieved on:

水曜日, 3月 13, 2024

Consolidated operating profit is projected to rise to between €300 million and €350 million in 2024, even though the Bank anticipates continued above-average risk provisions.

Key Points:

Consolidated operating profit is projected to rise to between €300 million and €350 million in 2024, even though the Bank anticipates continued above-average risk provisions.
Aareal Bank Group closed the 2023 financial year with consolidated operating profit of €149 million (2022: €239 million).
Thanks to its strong earnings power, the Group nonetheless anticipates consolidated operating profit between €300 million and €350 million.
The Bank is expected to achieve operating profit of €250 million to €300 million, despite risk provisions projected to remain at above-average levels.

Draft guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations

Retrieved on:

火曜日, 3月 12, 2024

Filtration, Vespula, Toxicity, Histamine, EAACI, Immunotherapy, Asthma, Report, Allergy, Skin, Pregnancy, PR, EEC, MITES, RNA, Criterion, History, CMR, Contraindication, HEP, Draft, Guideline, Patient, Ames test, Diagnosis, Dermatitis, Venom, Literature, Trial of the century, Reproduction, Silicon–germanium, SPT, Food allergy, Cosmetics, EECS, Absorption, Marketing, Safety, Data collection, Directive 2001/83/EC, GMP, ID50, Antibody, Documentation, European, Type IV hypersensitivity, Genotoxicity, Applicant (sketch), Aeroallergen, CHMP, PRIME, Immunoglobulin G, Type, Publication, Biology, Pollen, DNA, Environment, Immune system, Toolbox, NLN, AIT, Atopic dermatitis, Fatality, Chapter, Anaphylaxis, Process validation, ICH, Antigen, Rhinitis, Clinical trial, Erythema, Knowledge, Prescription, Human, Network, Medication, Scope, VIT, ICT, EMA, Collection, Macrophage, Outline, Metabolism, Registry, Inflammation, Immunoglobulin E, Nature, European Pharmacopoeia, Food, Risk, Prevalence, Mastocytosis, Observation, Cytokine, NPP, Patient safety, Disease, Finished, Medical device

16

Key Points:

16
Guideline on allergen products development for
immunotherapy and allergy diagnosis in moderate to lowsized study populations

17

Table of contents

18

Executive summary ..................................................................................... 3

19

1.
Specific effects ................................................................................................. 17
14
15

Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024

Page 2/18

53

12.
Management for allergies may involve avoidance of the allergen, medications to relieve
66

symptoms, or allergen immunotherapy (AIT) to desensitize the immune system to the allergen.
71
Recommendations are made on the clinical development, potential study designs and safety

72

considerations for allergen products within the scope of the guideline.
Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024
Page 3/18

88

While allergen specific immunotherapy is the only known disease modifying therapy for type I allergies,

89

there is no such treatment available for type IV allergies.
93
Several guidelines applicable for allergen products are available (see section 3) and provide advice on

94

quality and clinical development according to the current knowledge.
Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024
Page 4/18

127

However, this guideline does not cover the indication of atopic dermatitis or asthma as these

128

conditions will require separate clinical trials (see Section 6).
129
In addition, the guideline does not cover medicinal allergen products manufactured using recombinant

130

DNA technology, synthetic peptides, DNA or RNA constructs and/or cell preparations as they differ

131

substantially to the allergen products as discussed above.
1
156

?

Guideline on the clinical development of products for specific immunotherapy for the treatment

157
158

of allergic diseases - CHMP/EWP/18504/2006
?

159
160
161

Guideline on Allergen Products: Production and Quality Issues EMEA/CHMP/BWP/304831/2007

?

Guideline on process validation for finished products - information and data to be provided in
regulatory submissions - EMA/CHMP/CVMP/QWP/BWP/70278/2012-Rev1, Corr.1

Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024

Page 5/18

162

?

Recommendations on common regulatory approaches for allergen products - CMDh/399/2019

163

4.
In any
199

case, a reduced validation should include all relevant manufacturing process steps that are considered
Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024

Page 6/18

200

product specific.
290
Diagnostic allergen products (Type I allergy)

291

A possible target indication is diagnosis of type I hypersensitivity (immediate-type allergy) by prick,

292

intracutaneous or provocation testing.
298
Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024

Page 9/18

305
306

7.1.
Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024
Page 11/18

377

8.
Clinical development of products for AIT: Study design,
efficacy and safety
378

In general, the clinical development should be performed according to current guidelines.
In such single trial, the suitability as a test allergen as well as the
376

Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024

Page 12/18

415

dose finding for the therapeutic allergen could be investigated.
Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024
Page 13/18

454
455

8.2.1.
493
Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024

Page 15/18

527

In general, sensitivity and specificity of the product should be determined.
540
Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024

Page 16/18

561

10.2.
Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024
Page 17/18

595

4.
Allergol Immunopathol, 1989;
602

17(2):53-65

603

Guideline on allergen products development for immunotherapy and allergy diagnosis
in moderate to low-sized study populations
EMA/CHMP/72790/2024

Page 18/18

Distribution in Pharmaceuticals and Biotechnology Partnering Deal Trends Report 2024: Analysis of Agreements Signed Since 2016 Featuring Over 1,500 Companies - ResearchAndMarkets.com

Retrieved on:

金曜日, 3月 8, 2024

Biotechnology, Pharmaceutical, Health, Chapter Three, A-Z, Chapter Five, Chapter One, Directory, Confidentiality, Orientation, Chapter, Chapter Six, Chapter Four, Lease

The "Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.
Distribution Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter distribution deals with details of distribution deals from 2016 to 2024.
The report provides access to distribution deal payment terms as announced between the parties.
Contract documents provide an in-depth insight into the actual deal terms agreed between the parties with respect to the distribution deal.

Women of Global Change Seeks Inspirational Leaders to Serve as New Chapter Presidents

Retrieved on:

水曜日, 2月 28, 2024

Social change, Education, WGC, Chapter, Organization, Movement, Woman, Social justice, Nursing

LAGUNA HILLS, Calif., Feb. 28, 2024 /PRNewswire-PRWeb/ -- The Women of Global Change (WGC), an esteemed international network dedicated to fostering positive change through service, leadership, and action, is thrilled to announce a call for new Chapter Presidents globally. Recognized for its impactful contributions and honored with five Presidential Service Awards, WGC invites driven and compassionate leaders to spearhead its expansion and further its mission.

Key Points:

The Women of Global Change (WGC) is actively seeking dynamic leaders to serve as Chapter Presidents worldwide.
Serving as a WGC Chapter President presents an opportunity to lead meaningful projects, network with global changemakers, and collaborate with organizations to enhance community well-being.
WGC encourages motivated individuals who aspire to drive positive change and connect with an empowering network to apply for this transformative role.
LAGUNA HILLS, Calif., Feb. 28, 2024 /PRNewswire-PRWeb/ -- The Women of Global Change (WGC), an esteemed international network dedicated to fostering positive change through service, leadership, and action, is thrilled to announce a call for new Chapter Presidents globally.

Women of Global Change Uganda Chapter Launches Campaign to Provide Uniforms and School Supplies for Children

Retrieved on:

水曜日, 2月 28, 2024

WGC, Chapter, Child, Social change, Empowerment, Education, Woman, Nursing

KAMPALA, Uganda, Feb. 27, 2024 /PRNewswire-PRWeb/ -- The Women of Global Change (WGC) Uganda Chapter, under the dedicated leadership of Chapter President Becky Nakiwanuka, announces an inspiring campaign aimed at providing essential school uniforms and supplies to children. With each uniform costing about $40, the initiative seeks to ease the burden on families, for whom a single uniform often serves multiple children over the years.

Key Points:

The Women of Global Change Uganda Chapter has launched a campaign to provide school uniforms and supplies to children in need, with each uniform costing around $40.
The Uganda Chapter's efforts reflect WGC's global mission to foster social change and development through practical support and community engagement.
KAMPALA, Uganda, Feb. 27, 2024 /PRNewswire-PRWeb/ -- The Women of Global Change (WGC) Uganda Chapter, under the dedicated leadership of Chapter President Becky Nakiwanuka, announces an inspiring campaign aimed at providing essential school uniforms and supplies to children.
Education is the cornerstone of development, and by providing these uniforms, we are investing in the future leaders of Uganda."

Women of Global Change Philippine Chapter Illuminates Lives with Project LUV

Retrieved on:

日曜日, 2月 25, 2024

Local government, Project, WGC, LUV, Empowerment, Hope, Volunteering, Chapter, Woman

BAGUIO CITY, Philippines, Feb. 24, 2024 /PRNewswire-PRWeb/ -- The Women of Global Change (WGC) Philippine Chapter proudly announces the successful completion of its outreach event, Project LUV (Light Up the Villages), marking a significant step towards environmental sustainability and community empowerment in Baguio City.

Key Points:

The Women of Global Change (WGC) Philippine Chapter successfully completed its Project LUV (Light Up the Villages) outreach in Baguio City, distributing 14 solar light kits and groceries in Barangay Happy Hallow, followed by a Circular Economy Workshop.
BAGUIO CITY, Philippines, Feb. 24, 2024 /PRNewswire-PRWeb/ -- The Women of Global Change (WGC) Philippine Chapter proudly announces the successful completion of its outreach event, Project LUV (Light Up the Villages), marking a significant step towards environmental sustainability and community empowerment in Baguio City.
The Women of Global Change operates on the principles of global business, camaraderie, and service, actively engaging in social impact projects, educational platforms, and humanitarian efforts worldwide.
For more information about the Women of Global Change and their projects, visit WGC website .

Texas Financial Educators Council Will Donate Free Financial Education Resources to Community Organizations

Retrieved on:

水曜日, 2月 7, 2024

Certification, United States Census Bureau, Chapter, Housing, Safety, Athlete, School, MBA, Empowerment, Council, Accreditation, Education, TFEC, Organization, Green, Nursing

AUSTIN, Texas, Feb. 7, 2024 /PRNewswire/ -- Courtesy of the Texas Financial Educators Council (TFEC), nonprofit organizations and schools across the state now will receive complimentary financial education resources.

Key Points:

AUSTIN, Texas, Feb. 7, 2024 /PRNewswire/ -- Courtesy of the Texas Financial Educators Council (TFEC), nonprofit organizations and schools across the state now will receive complimentary financial education resources.
These highly-qualified speakers belong to the prestigious team of Certified Financial Education Instructors (CFEI®) trained by the National Financial Educators Council via training that gives them the skills and expertise to offer sustainable, scalable financial education programs.
The Texas Financial Educators Council has set a near-term goal of making a positive difference in financial literacy rates in Texas.
The Texas Financial Educators Council is one state branch of the National Financial Educators Council, a Certified B Corporation® and Accredited Provider through IACET, the leading continuing education accrediting body.